Corvus Pharmaceuticals Inc (CRVS)
8.94
+0.70
(+8.50%)
USD |
NASDAQ |
Nov 21, 16:00
8.90
-0.04
(-0.45%)
After-Hours: 20:00
Corvus Pharmaceuticals Net Income (Quarterly): -40.22M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -40.22M |
| June 30, 2024 | -4.262M |
| March 31, 2024 | -5.701M |
| December 31, 2023 | -6.653M |
| September 30, 2023 | -6.00M |
| June 30, 2023 | -6.503M |
| March 31, 2023 | -7.873M |
| December 31, 2022 | -9.816M |
| September 30, 2022 | -14.83M |
| June 30, 2022 | -8.363M |
| March 31, 2022 | -8.297M |
| December 31, 2021 | -9.236M |
| September 30, 2021 | -10.67M |
| June 30, 2021 | -11.75M |
| March 31, 2021 | -11.58M |
| December 31, 2020 | 27.35M |
| September 30, 2020 | -9.796M |
| June 30, 2020 | -10.61M |
| March 31, 2020 | -12.94M |
| December 31, 2019 | -11.05M |
| Date | Value |
|---|---|
| September 30, 2019 | -11.00M |
| June 30, 2019 | -12.98M |
| March 31, 2019 | -11.64M |
| December 31, 2018 | -10.51M |
| September 30, 2018 | -10.50M |
| June 30, 2018 | -11.63M |
| March 31, 2018 | -14.30M |
| December 31, 2017 | -11.93M |
| September 30, 2017 | -12.72M |
| June 30, 2017 | -14.98M |
| March 31, 2017 | -16.04M |
| December 31, 2016 | -11.09M |
| September 30, 2016 | -10.30M |
| June 30, 2016 | -8.645M |
| March 31, 2016 | -6.347M |
| December 31, 2015 | -6.039M |
| September 30, 2015 | -3.151M |
| June 30, 2015 | -20.23M |
| March 31, 2015 | -1.913M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-40.22M
Minimum
Sep 2024
27.35M
Maximum
Dec 2020
-8.940M
Average
-9.516M
Median
Net Income (Quarterly) Benchmarks
| Azenta Inc | -4.984M |
| Perspective Therapeutics Inc | -15.12M |
| Atara Biotherapeutics Inc | -21.91M |
| Clearside Biomedical Inc | -7.688M |
| Quanterix Corp | -9.473M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 7.255M |
| EPS Diluted (Quarterly) | -0.60 |
| Enterprise Value | 532.81M |
| Earnings Yield | -10.29% |